Literature DB >> 33603747

Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules.

Jin Kyung Seok1, Han Chang Kang1, Yong-Yeon Cho1, Hye Suk Lee1, Joo Young Lee1.   

Abstract

Inflammation is a host protection mechanism that eliminates invasive pathogens from the body. However, chronic inflammation, which occurs repeatedly and continuously over a long period, can directly damage tissues and cause various inflammatory and autoimmune diseases. Pattern recognition receptors (PRRs) respond to exogenous infectious agents called pathogen-associated molecular patterns and endogenous danger signals called danger-associated molecular patterns. Among PRRs, recent advancements in studies of the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome have established its significant contribution to the pathology of various inflammatory diseases, including metabolic disorders, immune diseases, cardiovascular diseases, and cancer. The regulation of NLRP3 activation is now considered to be important for the development of potential therapeutic strategies. To this end, there is a need to elucidate the regulatory mechanism of NLRP3 inflammasome activation by multiple signaling pathways, post-translational modifications, and cellular organelles. In this review, we discuss the intracellular signaling events, post-translational modifications, small molecules, and phytochemicals participating in the regulation of NLRP3 inflammasome activation. Understanding how intracellular events and small molecule inhibitors regulate NLRP3 inflammasome activation will provide crucial information for elucidating the associated host defense mechanism and the development of efficient therapeutic strategies for chronic diseases.
Copyright © 2021 Seok, Kang, Cho, Lee and Lee.

Entities:  

Keywords:  cell signaling; inflammation; innate immunity; pattern-recognition receptors; pharmacological inhibitor

Mesh:

Substances:

Year:  2021        PMID: 33603747      PMCID: PMC7884467          DOI: 10.3389/fimmu.2020.618231

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  127 in total

1.  The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation.

Authors:  T Fernandes-Alnemri; J Wu; J-W Yu; P Datta; B Miller; W Jankowski; S Rosenberg; J Zhang; E S Alnemri
Journal:  Cell Death Differ       Date:  2007-06-29       Impact factor: 15.828

2.  MAVS Promotes Inflammasome Activation by Targeting ASC for K63-Linked Ubiquitination via the E3 Ligase TRAF3.

Authors:  Kai Guan; Congwen Wei; Zirui Zheng; Ting Song; Feixiang Wu; Yanhong Zhang; Ye Cao; Shengli Ma; Wei Chen; Quanbin Xu; Weiwei Xia; Jun Gu; Xiang He; Hui Zhong
Journal:  J Immunol       Date:  2015-04-06       Impact factor: 5.422

3.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

4.  Saturated Fatty Acids Undergo Intracellular Crystallization and Activate the NLRP3 Inflammasome in Macrophages.

Authors:  Tadayoshi Karasawa; Akira Kawashima; Fumitake Usui-Kawanishi; Sachiko Watanabe; Hiroaki Kimura; Ryo Kamata; Koumei Shirasuna; Yutaro Koyama; Ayana Sato-Tomita; Takashi Matsuzaka; Hiroshi Tomoda; Sam-Yong Park; Naoya Shibayama; Hitoshi Shimano; Tadashi Kasahara; Masafumi Takahashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-08       Impact factor: 8.311

5.  Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome.

Authors:  Katherine Labbé; Christian R McIntire; Karine Doiron; Philippe M Leblanc; Maya Saleh
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

6.  NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx.

Authors:  Michael A Katsnelson; Kristen M Lozada-Soto; Hana M Russo; Barbara A Miller; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2016-05-11       Impact factor: 4.249

7.  Pannexin 1 Channels Contribute to IL-1β Expression via NLRP3/Caspase-1 Inflammasome in Aspergillus Fumigatus Keratitis.

Authors:  Xuejiao Yang; Guiqiu Zhao; Junwei Yan; Rui Xu; Chengye Che; Hengrui Zheng; Guoqiang Zhu; Jie Zhang
Journal:  Curr Eye Res       Date:  2019-03-29       Impact factor: 2.424

8.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

9.  Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.

Authors:  Hye Eun Lee; Gabsik Yang; Nam Doo Kim; Seongkeun Jeong; Yunjin Jung; Jae Young Choi; Hyun Ho Park; Joo Young Lee
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

10.  New mitochondrial DNA synthesis enables NLRP3 inflammasome activation.

Authors:  Zhenyu Zhong; Shuang Liang; Elsa Sanchez-Lopez; Feng He; Shabnam Shalapour; Xue-Jia Lin; Jerry Wong; Siyuan Ding; Ekihiro Seki; Bernd Schnabl; Andrea L Hevener; Harry B Greenberg; Tatiana Kisseleva; Michael Karin
Journal:  Nature       Date:  2018-07-25       Impact factor: 49.962

View more
  13 in total

1.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

Review 2.  Inflammasome activation: from molecular mechanisms to autoinflammation.

Authors:  Samuel Lara-Reyna; Emily A Caseley; Joanne Topping; François Rodrigues; Jorge Jimenez Macias; Sean E Lawler; Michael F McDermott
Journal:  Clin Transl Immunology       Date:  2022-07-07

Review 3.  Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases.

Authors:  Meini Chen; Rong Rong; Xiaobo Xia
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

4.  Integrative Characterization of the Role of IL27 In Melanoma Using Bioinformatics Analysis.

Authors:  Chunyu Dong; Dan Dang; Xuesong Zhao; Yuanyuan Wang; Zhijun Wang; Chuan Zhang
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

Review 5.  The Crucial Role of NLRP3 Inflammasome in Viral Infection-Associated Fibrosing Interstitial Lung Diseases.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2021-09-28       Impact factor: 5.923

Review 6.  The Role of PPAR Alpha in the Modulation of Innate Immunity.

Authors:  Maja Grabacka; Małgorzata Pierzchalska; Przemysław M Płonka; Piotr Pierzchalski
Journal:  Int J Mol Sci       Date:  2021-09-29       Impact factor: 5.923

7.  Intra-articular Injection of Baicalein Inhibits Cartilage Catabolism and NLRP3 Inflammasome Signaling in a Posttraumatic OA Model.

Authors:  Hui Bai; Rui Yuan; Zhiheng Zhang; Lin Liu; Xinyu Wang; Xiaopeng Song; Tianwen Ma; Jilang Tang; Chunpeng Liu; Li Gao
Journal:  Oxid Med Cell Longev       Date:  2021-09-02       Impact factor: 6.543

Review 8.  Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout.

Authors:  Jun Ho Lee; Hyuk Soon Kim; Jun-Ho Lee; Gabsik Yang; Hong Jun Kim
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

Review 9.  Inflammation and atherosclerosis: signaling pathways and therapeutic intervention.

Authors:  Peng Kong; Zi-Yang Cui; Xiao-Fu Huang; Dan-Dan Zhang; Rui-Juan Guo; Mei Han
Journal:  Signal Transduct Target Ther       Date:  2022-04-22

10.  Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor.

Authors:  Simone Gastaldi; Valentina Boscaro; Eleonora Gianquinto; Christina F Sandall; Marta Giorgis; Elisabetta Marini; Federica Blua; Margherita Gallicchio; Francesca Spyrakis; Justin A MacDonald; Massimo Bertinaria
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.